Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks KNBJN!
Don't give to many prognostics JG.
So far It hasn't been working very well for you !
Mr Market change his opinion all the time.
And that is a smart post!
Great unswear DK.
FN
Today was a nice little run:
2.82+0.10(3.68%)3:59 PMEST
EbolaCide2 might be the only cure to stop the epidemic.
Ebola crisis: 'Too slow' WHO promises reforms
Ebola outbreak
The World Health Organization (WHO) has set out plans for reform, admitting that it was too slow to respond to the deadly Ebola outbreak in West Africa.
At an emergency session in Geneva, director-general Margaret Chan said Ebola had taught the world and the WHO how they must act in the future.
She said the corner had been turned on infections but warned over complacency.
More than 8,500 people have died in the outbreak, the vast majority in Sierra Leone, Guinea and Liberia.
Contingency fund
Dr Chan said: "This was West Africa's first experience with the virus and it delivered some horrific shocks and surprises.
"The world, including WHO, was too slow to see what was unfolding before us. Ebola is a tragedy that has taught the world, including WHO, many lessons about how to prevent similar events in the future."
The WHO says patient database figures give the best representation of the history of the epidemic. However, data for more recent weeks are sometimes less complete than in the regular situation reports
Dr Chan said that although disease outbreaks would continue to deliver shocks, "never again should the world be caught by surprise, unprepared".
The reforms announced included a "dedicated contingency fund to support rapid responses to outbreaks and emergencies".
There would also be improvements in international co-ordination and greater support for countries that needed to respond quickly to emergencies.
Dr Chan: "We must maintain the momentum and guard against complacency"
This would also require vaccines and drugs to be brought to the market more speedily.
Liberia announced on Friday that it was down to just five confirmed cases - there were 500 a week in September. Guinea and Sierra Leone have both also experienced falls in infection rates.
Dr Chan said the worst-case scenario had been avoided, but warned: "We must maintain the momentum and guard against complacency and donor fatigue."
WHO figures show 21,724 reported cases of Ebola in the outbreak , with 8,641 deaths.
Welcome back BK!
I was wondering where you were.
It's al about risk Rawnoc and you know that! But is it worth it ?
For me it is!
Why?
Because I believe in progress.
Is NNVC part of a change for a better future?
You bet it is
FN
I disagree!
Yes it is a risk! Everything is a risk!
I take a risk every days of my life driving to work.
There are always risks in business
Ebola is a risk but a great opportunity for NNVC. If it works the company will prove to the world that they are the only one in the biotech history to win against Ebola. And that will be an amazing advertising for the company.
They have enough money in the bank to work with FluCide and there is a BIG possibility that they will succeed !
The first tests passed!
So GO NNVC!
R2
Thanks so much for sharing.
FN
Thank you Rearden!
HAHAHA!!!!!
LOL
I have to laugh when I read your posts
I know that! You said that all along !
And that where you have been wrong.
Not at all. you always criticized the company and its executives.
I have uploaded a post yesterday on every thing you said about NNVC
it is in your history, and it's very easy for me to post them again.
LOL
You haven't been correct so far with your predictions.
The stock could be much higher than that at the end of the year!
FN
I would not be surprised, that they have already started the next step for FluCide.
It is going to be fast.
FN
The next phase of the toxicology package studies will involve larger animals, and will require much larger quantities of the drug candidate. The Company is in the process of commissioning operations at the new 1 Controls Drive, Shelton, CT facility in order to perform the scale up studies needed for making the large quantities of materials in a controlled manner. These upcoming studies will be performed in cGLP compliant manner to provide safety and toxicology data that are required for an IND submission to regulatory agencies.
So exciting.
2015 starts very well.
FluCide tox succeeded,
EbolaCide has a good chance of succeeding too.
Get ready for the next maneuver from the compagny. It's going to be big.
FN
Bravo to NNVC beings in times as they had predicted.
And I know it.
I know, but it's a business. and you will always have people who will do anything for money.
Do not worry. Believe in your uncle and the company.
That's what matters.
FN
You uncle is an amazing man.
NNVC is lucky to have him on board.
FN
Very interesting debate.
The most important is what the company is doing.
Until now NNVC proved to everyone what the company is capable of.
And the market is buying: $ 2.84 ? 0.29 (11.37%)
NNVC is going to succeed.
FN
You are pleased
Great post L vus!
Whatever man.
NNVC is back above 3.00 in an hour from the opening market.
Today investors are realizing the true value of the company.
FN
You contradict yourself:
Now the stock will return to its normal price.
And be ready for the next PR.
Coming soon.
FN
Yes I see!
Well I am seeing that on the 12 in the morning the stock went to 2.58
So he had the time to buy it at 2.57 and 2.54
the PR say that they bought between the 6th and The 13th
On the last day the stock went to 2.80
FN
Thanks Bloom!
You're welcome bloom!
News are coming.
Do not worry my friend!
The following table shows the largest shareholders in NANOVIRICIDES INC COM (NNVC) for the quarter ended December 31, 2014, listed by holding size. The list represents up to 50 of the largest holders in the company.
http://imarketreports.com/nanoviricides-inc-inst-holders-4q-2014-nnvc.html
Note: Unless otherwise mentioned the reporting date is 12/31/2014
Institution Shares Shares % Last
Held Changed Held Report
BlackRock Fund Advisors 1,311,115 (20,951) 2.248 09/30
The Vanguard Group Inc. 1,081,082 134,781 1.854 09/30
Northern Trust Investments In 425,932 316,534 0.730 09/30
SSgA Funds Management Inc. 382,527 12,235 0.656 09/30
Geode Capital Management LLC 204,531 0 0.351 09/30
TIAA-CREF Investment Managemen 149,200 0 0.256 09/30
Bridgeway Capital Management 143,000 0 0.245 09/30
Goldman Sachs & Co. (Private B 130,931 (94,932) 0.224 09/30
The Bank of New York Mellon Co 123,946 6,800 0.213 09/30
BlackRock Investment Managemen 116,483 3,223 0.200 09/30
The Colony Group LLC 85,724 0 0.147 09/30
AQR Capital Management LLC 82,100 0 0.141 09/30
California State Teachers Reti 73,620 420 0.126 09/30
StoneRidge Investment Partners 60,891 60,891 0.104 09/30
Deutsche Bank Securities Inc. 60,414 10,217 0.104 09/30
Staley Capital Advisers Inc. 60,000 0 0.103 09/30
Charles Schwab Investment Mana 58,800 0 0.101 09/30
Susquehanna Financial Group LL 57,260 57,260 0.098 09/30
Teachers Advisors Inc. 55,430 0 0.095 09/30
Mellon Capital Management Corp 48,765 (187) 0.084 09/30
Weatherly Asset Management LP 42,644 0 0.073 09/30
Bartlett & Co. LLC 40,714 0 0.070 09/30
Voya Investment Management Co. 39,869 0 0.068 09/30
UBS Financial Services Inc. 35,011 12,300 0.060 09/30
Nationwide Fund Advisors 30,558 477 0.052 09/30
Ferguson Wellman Capital Manag 28,572 0 0.049 09/30
RhumbLine Advisers Ltd. Partne 28,390 2,050 0.049 09/30
Rathbone Investment Management 28,250 0 0.048 09/30
SunAmerica Asset Management LL 26,204 (19) 0.045 09/30
Morgan Stanley Smith Barney LL 24,839 909 0.043 09/30
Tower Research Capital LLC 22,186 18,413 0.038 09/30
KCG Americas LLC 19,750 19,750 0.034 09/30
RNC Capital Management LLC 17,143 0 0.029 09/30
BlackRock Advisors LLC 16,944 0 0.029 09/30
Jacobs Levy Equity Management 16,700 1,300 0.029 09/30
ProShare Advisors LLC 15,930 (3,605) 0.027 09/30
Manulife Asset Management (US) 15,903 (785) 0.027 09/30
Manulife Asset Management Ltd. 10,062 (1,285) 0.017 09/30
Citadel Advisors LLC 8,091 (21,635) 0.014 09/30
UBS Securities LLC 7,808 7,808 0.013 09/30
Wells Fargo Bank NA (Private 6,275 (1,006) 0.011 09/30
North Star Investment Manageme 6,000 0 0.010 09/30
Bank of America NA (Private B 3,529 0 0.006 09/30
West Financial Services Inc. 3,314 960 0.006 09/30
Ladenburg Thalmann Asset Manag 2,866 1,865 0.005 09/30
BMO Capital Markets (Canada) 2,857 0 0.005 09/30
AllianceBernstein LP 2,800 (2,800) 0.005 09/30
BNP Paribas Arbitrage SNC 2,417 2,417 0.004 09/30
Creative Planning Inc. 2,286 0 0.004 09/30
D. A. Davidson & Co. 1,886 0 0.003 09/30
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2015. All Rights Reserved.
Hey daBoze!
How are you?